Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-850
Closed -$269K 61
2020
Q1
$269K Hold
850
0.04% 61
2019
Q4
$252K Sell
850
-13,280
-94% -$3.68M 0.03% 84
2019
Q3
$3.29M Hold
14,130
0.36% 43
2019
Q2
$3.31M Sell
14,130
-130
-0.9% -$30K 0.36% 45
2019
Q1
$3.37M Hold
14,260
0.35% 47
2018
Q4
$4.29M Hold
14,260
0.48% 43
2018
Q3
$5.04M Sell
14,260
-5,680
-28% -$1.96M 0.51% 40
2018
Q2
$5.79M Sell
19,940
-2,780
-12% -$782K 0.64% 36
2018
Q1
$6.22M Hold
22,720
0.73% 30
2017
Q4
$7.24M Hold
22,720
0.85% 27
2017
Q3
$7.11M Hold
22,720
0.92% 26
2017
Q2
$6.17M Buy
22,720
+720
+3% +$190K 0.83% 28
2017
Q1
$6.01M Sell
22,000
-3,000
-12% -$848K 0.86% 26
2016
Q4
$7.09M Sell
25,000
-20,800
-45% -$6.17M 1.01% 23
2016
Q3
$14.3M Buy
45,800
+2,000
+5% +$592K 1.7% 16
2016
Q2
$10.6M Buy
43,800
+30,600
+232% +$8.06M 1.22% 24
2016
Q1
$3.44M Buy
13,200
+10,400
+371% +$2.75M 0.4% 43
2015
Q4
$858K Buy
+2,800
New +$805K 0.12% 58

Other funds holding BIIB

Hikari Power's BIIB Position: Q2 2020 in Review

Hikari Power sold out of Biogen (BIIB) in Q2 2020, closing a stake of 850 shares — an estimated $269K sold.

Hikari Power first reported a position in BIIB in Q4 2015 and held it in 18 quarters. The position peaked at $14.3M in Q3 2016. 1,060 funds tracked by Wall St. Rank hold BIIB as of Q2 2020.

  • Hikari Power reported no remaining Biogen position as of Q2 2020 after selling out during the quarter.
  • Hikari Power sold 850 Biogen shares in Q2 2020, an estimated $269K.
  • Hikari Power first reported a position in Biogen in Q4 2015 and held it in 18 quarters.
  • Hikari Power's Biogen position peaked at $14.3M in Q3 2016.
  • 1,060 funds tracked by Wall St. Rank held Biogen as of Q2 2020.

Based on Hikari Power's 13F filing for Q2 2020, filed 13 Aug 2020.